Patient Experience Data in Radiation Oncology
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-100
SponsorMedical University of Vienna
About this trial
The project is part of the overarching goal of improving patient-centric radiation oncology. This pilot project aims to develop an instrument that can be used to collect clinically relevant patient-reported outcome data on adverse effects during and after RT. This real-world evidence (RWE) database will be the basis to monitor and evaluate future technological developments, combination treatments (e.g. radioimmunotherapy, etc.), or changes in treatment protocols. The pseudonymized data will be linked to data in the oncological information system and dosimetric data from the treatment planning system. In this way, they represent a basic building block of patient-oriented development of clinical radiotherapy.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
all patients receiving external beam radiotherapy
Disqualifiers
unable to independently answer questionnaires on radiation-induced side effects
Trial population
The study is aimed to include a comprehensive representative cross-section for each of the study groups.
Trial design
Design model
Cohort
Time perspective
Prospective
Treatments tested in this trial
external beam photon therapy
RadiationPatients receive external beam photon therapy for different tumor locations (groups).
Treatment groups
6,000 Participants
are divided into 9 treatment groups9
Treatment groupsSee each treatment group below.
Group A: breast1 intervention
Group B: thorax1 intervention
Group C: skin1 intervention
Group D: abdomen1 intervention
Group E: skull1 intervention
Group F: head and neck1 intervention
Group G: pelvis male1 intervention
Group H: pelvis female1 intervention
Group I: extremities1 intervention
Trial outcomes
Primary outcomes
1
radiation-related side effects
Time frame
during radiotherapy and after (up until 5 years)Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov